Effects of Probiotics on Human Obesity Control: An Unproven Hypothesis
DOI:
https://doi.org/10.14306/renhyd.16.3.75Keywords:
Obesity, Metagenome, Probiotic, Body weight controlAbstract
The objective of the present study is to review the different publications associated with probiotics and obesity, as well as to get some new insights regarding the role of the microbiome in diseases such as obesity. An extensive search for scientific publications (studies in animal models, cells, clinical trials and reviews) was performed in the following specialist computer databases (PubMed central (PMC)-NCBI, Elsevier Journal, Scielo Spain, Scirus, Science Direct) to establish the current status of the potential effect of probiotics in the control of obesity in humans, as well as the relationship between intestinal microbiota and obesity. The intestinal microbiota and oral probiotics have a positive effect on human health, as they can regulate the immune functions and protect from infections and chronic inflammatory processes. Although divergent results have recently been reported, it has been shown but not confirmed that intestinal microbiota might play a role as a new factor associated with the regulation of body weight and obesity-related diseases. The international MetaHIT project has shown that human microbiome populations can be grouped into three different enterotypes. Two of these enterotypes (Bacteroides and Ruminococcus) seem to encode functions related to obesity. Although the relationship between intestinal microbiota and obesity are not yet well established, the attempt to manipulate intestinal microbiota through diet is suggested as a new plausible approach to prevent, or modify the risk of, obesity and its related diseases.References
Basulto J, Manera M, Baladia E. Postura del GREP-AEDN: la obesidad como enfermedad. Act Diet. 2008;12:98-9.
Raoult D. Probiotics and obesity: a link? Nat Rev Microbiol. 2009;7:616.
Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature. 2011;473:174-80.
Ortiz H, Galán I, Martín López R, et al. Prevalencia de sobrepeso y obesidad y efectos en la mortalidad atribuible en la comunidad de Madrid. Bol Epidemiol Com Madrid. 2010;16(6).
Ministerio de Sanidad y Política Social – Campaña 2007. Situación actual y tendencia en España [Internet] [actualizado 23 Oct 2007]. Disponible en: http://www.msps.es/campannas/campanas06/obesidadInfant3.htm
Aranceta-Bartrina J, Serra-Majem L, Foz-Sala M, et al. Prevalence of obesity in Spain. Med Clin (Barc). 2005;125:460-6.
Banegas JR, Lopez-Garcia E, Gutierrez-Fisac JL, et al. A simple estimate of mortality attributable to excess weight in the European Union. Eur J Clin Nutr. 2003;57:201-8.
Zugasti Murillo A, Moreno Esteban B. Obesidad, factor de riesgo cardiovascular. Rev Esp Obes. 2005;3:89-94.
Salas-Salvadó J, Rubio MA, Barbany M, et al. Consenso SEEDO 2007 para la evaluación del sobrepeso y la obesidad y el esta blecimiento de criterios de intervención terapéutica. Med Clin (Barc). 2007;128:184-96.
Ashwell M. Concepto sobre los alimentos funcionales. Ilsi Europe Concise Monograph Series [edición electrónica] 2002. Disponible en: http://www.argenbio.org/adc/uploads/pdf/alimentosfuncionalesiLSI.pdf
Holzapfel WH, Haberer P, Snel J, et al. Overview of gut flora and probiotics. Int J Food Microbiol. 1998;41:85-101.
Klein G, Pack A, Bonaparte C, et al. Taxonomy and physiology of probiotic lactic acid bacteria. Int J Food Microbiol. 1998;41:103-25.
FAO/OMS 2006. Probióticos en los alimentos. Estudio FAO Alimentación y Nutrición 85. Disponible en: ftp://ftp.fao.org/docrep/fao/009/a0512s/a0512s00.pdf
Collins JK, Thornton G, O’Sullivan GO. Selection of probiotic strains for human applications. Int Dairy J. 1998;8:487-90.
Morelli L. In vitro selection of probiotic lactobacilli: A critical appraisal. Curr Issues Intestinal Microbiol. 2000;1:59-67.
Guarner F, Khan Aamir G, Garisch J, et al. Equipo de Revisión. Guías prácticas: probióticos y prebióticos. Organización Mundial de Gastroenterología; 2008.
Aguilera Garca M, Barberá Mateos JM, Diaz Ligia E, et al. Alimentos funcionales. Aproximación a una nueva alimentación. Inutcam: Dirección General de Salud Pública y Alimentación; 2008.
Tannock GW. Analysis of the intestinal microflora A renaissance. Antonie Van Leeuwenhoek. 1999;76:265-78.
Mitsuoka T. Intestinal flora and aging. Nutr Rev. 1992;50:438-46.
Goldin BR. Intestinal microflora: Metabolism of drugs and carcinogens. Ann Med. 1990;22:43-8.
Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia- induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;57:1470-81.
Bäckhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004;101:15718-23.
Ley RE, Bäckhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102:11070-5.
Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 2005;122:107-18.
Waldram A, Holmes E, Wang Y, et al. Top-down systems biology modeling of host metabotype- microbiome associations in obese rodents. J Proteome Res. 2009;8:2361-75.
Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027-31.
Turnbaugh PJ, Bäckhed F, Fulton L, et al. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008;3:213-23.
Cani PD, Neyrinck AM, Fava F, et al. Selective increases of bifidobacteria in gut microflora improves high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007;50:2374-83.
Onakpoya IJ, Posadzki PP, Watson LK, et al. The efficacy of long-term conjugated linoleic acid (CLA) supplementation on body composition in overweight and obese individuals: a systematic review and meta-analysis of randomized clinical trials. Eur J Nutr. 2012;51:127-34.
Rosberg-Cody E, Stanton C, O’Mahony L, et al. Recombinant lactobacilli expressing linoleic acid isomerase can modulate the fatty acid composition of host adipose tissue in mice. Microbiology. 2011;157(Pt 2):609-15.
Dusko Ehrlich S. Probiotics– little evidence for a link to obesity. Nat Rev Microbiol. 2009;7:901; autor reply 901.
Delzenne N, Reid G. No causal link between obesity and probiotics. Nat Rev Microbial. 2009;7:901; author reply 901.
Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444:1022-3.
Santacruz A, Collado MC, Azcona C, et al. Weight loss influences gut microbial composition in overweight adolescents. Obesity. 2009;23:1-10.
Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core guts microbiome in obese and lean twins. Nature. 2009;457:480-4.
Ilmonen J, Isolauri E, Poussa T, et al. Impact of dietary counselling and probiotic intervention on maternal anthropometric measurements during and after pregnancy: A randomized placebo-controlled trial. Clin Nutr. 2011;30:156-64.
Sanz Y, Santacruz A, Dalmau J. Influencia de la microbiota intestinal en la obesidad y las alteraciones del metabolismo. Acta Pediatr Esp. 2009;67:437-42.
Bukowska H, Pieczul-Mróz J, Jastrzebska M, Chelstowski K, Naruszewicz M. Decrease in fibrinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol. Atherosclerosis. 1998;137:437-8.
Naruszewicz M, Johansson ML, Zapolska-Downar D, Bukowska H. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr. 2002;76:1249-55.
Kiessling G, Schneider J, Jahreis G. Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur J Clin Nutr. 2002;56:843-9.
Simons LA, Amansec SG, Conway P. Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol. Nutr Metab Cardiovasc Dis. 2006;16:531-5.
Greany KA, Bonorden MJ, Hamilton-Reeves JM, McMullen MH, Wangen KE, Phipps WR, et al. Probiotic capsules do not lower plasma lipids in young women and men. Eur J Clin Nutr. 2008;62:232-7.
Cani PD, Joly E, Horsmans Y, Delzenne NM. Oligofructose promotes satiety in healthy human: a pilot study. Eur J Clin Nutr. 2006;60:567-72.
Abrams SA, Griffin IJ, Hawthorne KM, Ellis KJ. Effect of prebiotic supplementation and calcium intake on body mass index. J. Pediatr. 2007;151:293-8.
This journal 